全文获取类型
收费全文 | 6828篇 |
免费 | 1061篇 |
国内免费 | 3631篇 |
出版年
2024年 | 23篇 |
2023年 | 228篇 |
2022年 | 348篇 |
2021年 | 388篇 |
2020年 | 390篇 |
2019年 | 460篇 |
2018年 | 322篇 |
2017年 | 305篇 |
2016年 | 297篇 |
2015年 | 392篇 |
2014年 | 602篇 |
2013年 | 559篇 |
2012年 | 714篇 |
2011年 | 694篇 |
2010年 | 591篇 |
2009年 | 636篇 |
2008年 | 657篇 |
2007年 | 619篇 |
2006年 | 589篇 |
2005年 | 528篇 |
2004年 | 423篇 |
2003年 | 314篇 |
2002年 | 292篇 |
2001年 | 255篇 |
2000年 | 263篇 |
1999年 | 162篇 |
1998年 | 79篇 |
1997年 | 54篇 |
1996年 | 46篇 |
1995年 | 48篇 |
1994年 | 41篇 |
1993年 | 16篇 |
1992年 | 22篇 |
1991年 | 23篇 |
1990年 | 19篇 |
1989年 | 24篇 |
1988年 | 14篇 |
1987年 | 14篇 |
1986年 | 12篇 |
1985年 | 17篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 11篇 |
1981年 | 9篇 |
1980年 | 2篇 |
1976年 | 1篇 |
1950年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
植物叶片功能性状能够响应环境条件的变化,反应了植物对环境的适应策略。当前,针对藤本植物叶片功能性状地理格局及其环境驱动力的研究较少。以国家重点保护植物永瓣藤(Monimopetalum chinense)为研究对象,对其分布区内11个种群的15个叶片功能性状进行测量,并结合气候、土壤因子来解释叶性状变异。比较叶片性状在局域和区域尺度上的种内变异程度,利用多元逐步回归分析环境因子对叶性状的影响。结果表明,在局域尺度上,永瓣藤叶功能性状变异系数介于3.0%-22.5%,其中,叶面积变异程度最大,叶片碳含量变异最小。永瓣藤叶片形状随纬度上升而变得宽且圆。叶片磷含量相对较低,永瓣藤的生长可能受到了磷限制。土壤与气候因子是叶片性状的重要驱动因素,解释了25%-97%的叶片性状变异。在温度和水分充足的情况下,永瓣藤叶片趋向于的慢速生长的保守策略。总体来说,永瓣藤叶片功能性状通过一定的种内变异和性状组合,并与气候、土壤因子相互作用,适应当前的环境条件。 相似文献
2.
3.
4.
5.
20世纪90年代以来中国生态空间演化的时空格局和梯度效应 总被引:3,自引:0,他引:3
改革开放以来中国经济和城市化的快速发展促使生产和生活空间挤占大量生态空间,系统认识和评估我国生态空间演化的宏观格局和过程对于生态文明建设具有重要的理论和现实意义。为揭示全国生态空间变化的时空过程,在对生态空间内涵进行界定的基础上,结合全国尺度时序土地利用数据构建生态空间分类体系,并评估1990-2015年中国生态空间演化特征。结果表明:1990-2015年中国生态用地面积持续减少,主要向半生态用地转变,发生在重要的粮食生产区域及周边;半生态用地面积波动明显,前期主要表现为不断扩张,后期大量转换为弱生态用地,发生在主要城市群地区;弱生态用地持续扩张,与城镇化进程不断加速相关。中国生态空间演变过程表现出一定的区域差异和梯度效应,不同区域生态空间变化发生的拐点时间有所不同,呈现"自东向西、由南到北"的3级梯度特征,区域生态空间状况与经济发展战略及生态空间管控具有较强的相关性。本研究对于国家生态空间管控近远期战略方案制订具有一定启示,建议处于不同梯度的各地区应基于区域生态空间演化所处阶段和不同驱动机制,确定分区域生态空间安全红线目标和生态空间管控方案。 相似文献
6.
Jordan Khankhet Karen J. Vanderwolf Donald F. McAlpine Scott McBurney David P. Overy Durda Slavic Jianping Xu 《PloS one》2014,9(8)
Pseudogymnoascus destructans is the causative agent of an emerging infectious disease that threatens populations of several North American bat species. The fungal disease was first observed in 2006 and has since caused the death of nearly six million bats. The disease, commonly known as white-nose syndrome, is characterized by a cutaneous infection with P. destructans causing erosions and ulcers in the skin of nose, ears and/or wings of bats. Previous studies based on sequences from eight loci have found that isolates of P. destructans from bats in the US all belong to one multilocus genotype. Using the same multilocus sequence typing method, we found that isolates from eastern and central Canada also had the same genotype as those from the US, consistent with the clonal expansion of P. destructans into Canada. However, our PCR fingerprinting revealed that among the 112 North American isolates we analyzed, three, all from Canada, showed minor genetic variation. Furthermore, we found significant variations among isolates in mycelial growth rate; the production of mycelial exudates; and pigment production and diffusion into agar media. These phenotypic differences were influenced by culture medium and incubation temperature, indicating significant variation in environmental condition - dependent phenotypic expression among isolates of the clonal P. destructans genotype in North America. 相似文献
7.
Yuanyuan Zhang Yuhui Zhang Chunmei Li Shuai Fu Chunfeng Yang Yan Song Meilan Liu Zhenhua Wang Peili Liang Jianping Zhang 《Cell biochemistry and function》2019,37(7):464-473
We sought to explore the functions and modulated factors of NOD1 in normal decidual stromal cells (DSCs) derived from the first trimester pregnancy and whether existed different expression of NOD1 between normal and unexplained recurrent pregnancy loss (URPL) in DSCs. Twenty‐six patients with normal pregnancies that required abortion and 12 URPL patients at first trimester were enrolled for the study. As a result, we found lower levels of NOD1 in the DSCs derived from URPL compared with those from normal early trimester pregnancy. Furthermore, increased NOD1 expression in the normal DSCs induced apoptosis and increased monocyte chemotactic protein‐1 (MCP‐1) and IL‐1β (interleukin 1 beta) secretion but decreased their invasion capacity. In addition, several cytokines such as IL‐1β, tumour necrosis factor‐alpha (TNF‐α), interferon‐gamma (IFN‐γ), and interleukin‐17 (IL‐17) were present at the maternal‐fetal interface in RPL and were found to regulate NOD1 expression in primary DSCs. Our study indicates that RPL may be associated with NOD1 aberrant expression in DSCs, which plays a significant role in maintaining pregnancy via infection control and regulation of immune responses that might affect the pregnancy outcome. We expect that our results will bring more comprehensively understanding about the connection between NOD1 and RPL for researchers. 相似文献
8.
William Kong Lili He Marc Coppola Jianping Guo Nicole N. Esposito Domenico Coppola Jin Q. Cheng 《The Journal of biological chemistry》2010,285(23):17869-17879
Breast cancer is the second leading cause of cancer death in women. Despite improvement in treatment over the past few decades, there is an urgent need for development of targeted therapies. miR-155 (microRNA-155) is frequently up-regulated in breast cancer. In this study, we demonstrate the critical role of miR-155 in regulation of cell survival and chemosensitivity through down-regulation of FOXO3a in breast cancer. Ectopic expression of miR-155 induces cell survival and chemoresistance to multiple agents, whereas knockdown of miR-155 renders cells to apoptosis and enhances chemosensitivity. Further, we identified FOXO3a as a direct target of miR-155. Sustained overexpression of miR-155 resulted in repression of FOXO3a protein without changing mRNA levels, and knockdown of miR-155 increases FOXO3a. Introduction of FOXO3a cDNA lacking the 3′-untranslated region abrogates miR-155-induced cell survival and chemoresistance. Finally, inverse correlation between miR-155 and FOXO3a levels were observed in a panel of breast cancer cell lines and tumors. In conclusion, our study reveals a molecular link between miR-155 and FOXO3a and presents evidence that miR-155 is a critical therapeutic target in breast cancer. 相似文献
9.
10.